ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 26 filers reported holding ASTRAZENECA PLC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,054,302 | -7.3% | 15,890 | 0.0% | 0.58% | -0.9% |
| Q2 2023 | $1,137,247 | +3.1% | 15,890 | 0.0% | 0.59% | -0.3% |
| Q1 2023 | $1,102,925 | -9.1% | 15,890 | -11.2% | 0.59% | -6.8% |
| Q4 2022 | $1,212,942 | +23.6% | 17,890 | 0.0% | 0.63% | +25.1% |
| Q3 2022 | $981,000 | -17.5% | 17,890 | -0.6% | 0.50% | -18.2% |
| Q2 2022 | $1,189,000 | -2.0% | 17,990 | -1.6% | 0.62% | +0.8% |
| Q1 2022 | $1,213,000 | +13.9% | 18,290 | 0.0% | 0.61% | +20.7% |
| Q4 2021 | $1,065,000 | -3.6% | 18,290 | -0.5% | 0.51% | -11.7% |
| Q3 2021 | $1,105,000 | +0.3% | 18,390 | 0.0% | 0.57% | -3.2% |
| Q2 2021 | $1,102,000 | +20.6% | 18,390 | 0.0% | 0.59% | +11.9% |
| Q1 2021 | $914,000 | -0.5% | 18,390 | 0.0% | 0.53% | -14.5% |
| Q4 2020 | $919,000 | -9.6% | 18,390 | -0.9% | 0.62% | -8.8% |
| Q3 2020 | $1,017,000 | +3.6% | 18,565 | 0.0% | 0.68% | -0.4% |
| Q2 2020 | $982,000 | +18.5% | 18,565 | 0.0% | 0.68% | +0.7% |
| Q1 2020 | $829,000 | -15.4% | 18,565 | -5.6% | 0.68% | +13.9% |
| Q4 2019 | $980,000 | +9.6% | 19,665 | -2.0% | 0.60% | +4.4% |
| Q3 2019 | $894,000 | +6.0% | 20,065 | -1.7% | 0.57% | +0.2% |
| Q2 2019 | $843,000 | +2.7% | 20,415 | +0.5% | 0.57% | -0.9% |
| Q1 2019 | $821,000 | +8.0% | 20,315 | +1.5% | 0.57% | -7.6% |
| Q4 2018 | $760,000 | -3.6% | 20,015 | +0.5% | 0.62% | +13.1% |
| Q3 2018 | $788,000 | +12.7% | 19,915 | 0.0% | 0.55% | +7.2% |
| Q2 2018 | $699,000 | -0.1% | 19,915 | -0.5% | 0.51% | -1.2% |
| Q1 2018 | $700,000 | +0.7% | 20,015 | 0.0% | 0.52% | +5.1% |
| Q4 2017 | $695,000 | +1.2% | 20,015 | -1.4% | 0.49% | -2.6% |
| Q3 2017 | $687,000 | +4.7% | 20,290 | +5.5% | 0.51% | +11.9% |
| Q2 2017 | $656,000 | -35.4% | 19,240 | -44.4% | 0.45% | +24.2% |
| Q1 2017 | $1,015,000 | +131.7% | 34,590 | +115.5% | 0.36% | +12.0% |
| Q4 2016 | $438,000 | +6.1% | 16,050 | +27.7% | 0.32% | +3.8% |
| Q3 2016 | $413,000 | – | 12,565 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |